Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy : are there molecular markers in the primary tumour that predict for 5-year clinical outcome ?
Nom du journal : Ann Oncol
Année : 2003
Volume : 14
Page de départ : 406
Page de fin : 413